Global Blood Therapeutics Stock Filter Stocks by Fundamentals
GBTDelisted Stock | USD 68.49 0.00 0.00% |
Global Blood Therapeutics fundamentals help investors to digest information that contributes to Global Blood's financial success or failures. It also enables traders to predict the movement of Global Stock. The fundamental analysis module provides a way to measure Global Blood's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Global Blood stock.
Global |
Did you try this?
Run Global Markets Map Now
Global Markets MapGet a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |
All Next | Launch Module |
Global Fundamentals
Return On Equity | -124.53 | |||
Return On Asset | -23.82 | |||
Profit Margin | (146.82) % | |||
Operating Margin | (137.33) % | |||
Current Valuation | 2.24 B | |||
Shares Outstanding | 64.45 M | |||
Shares Owned By Insiders | 2.72 % | |||
Shares Owned By Institutions | 97.28 % | |||
Number Of Shares Shorted | 9.23 M | |||
Price To Earning | (13.97) X | |||
Price To Book | 10.19 X | |||
Price To Sales | 20.93 X | |||
Revenue | 210.87 M | |||
Gross Profit | 191.43 M | |||
EBITDA | (283.56 M) | |||
Net Income | (309.58 M) | |||
Cash And Equivalents | 553.42 M | |||
Cash Per Share | 8.50 X | |||
Total Debt | 659.05 M | |||
Debt To Equity | 4.92 % | |||
Current Ratio | 8.52 X | |||
Book Value Per Share | 6.72 X | |||
Cash Flow From Operations | (249.41 M) | |||
Short Ratio | 5.38 X | |||
Earnings Per Share | (4.04) X | |||
Price To Earnings To Growth | (0.19) X | |||
Number Of Employees | 457 | |||
Beta | 0.86 | |||
Market Capitalization | 4.41 B | |||
Total Asset | 153.07 M | |||
Retained Earnings | (758.36 M) | |||
Working Capital | 140.1 M | |||
Current Asset | 150.82 M | |||
Current Liabilities | 10.72 M | |||
Z Score | -4.3 |
About Global Blood Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Global Blood Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Global Blood using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Global Blood Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. Note that the Global Blood Therapeutics information on this page should be used as a complementary analysis to other Global Blood's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Global Stock
If you are still planning to invest in Global Blood Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Global Blood's history and understand the potential risks before investing.
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Transaction History View history of all your transactions and understand their impact on performance | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |